(L)-ASPARTIC ACID en es it fr

(L)-ASPARTIC ACID Brand names, (L)-ASPARTIC ACID Analogs

(L)-ASPARTIC ACID Brand Names Mixture

  • No information avaliable

(L)-ASPARTIC ACID Chemical_Formula



No information avaliable

(L)-ASPARTIC ACID fda sheet

(L)-ASPARTIC ACID msds (material safety sheet)


(L)-ASPARTIC ACID Synthesis Reference

No information avaliable

(L)-ASPARTIC ACID Molecular Weight

133.104 g/mol

(L)-ASPARTIC ACID Melting Point

230 oC

(L)-ASPARTIC ACID H2O Solubility

4.5 g/l




-0.67 +/- 0.36

(L)-ASPARTIC ACID Dosage Forms

Capsules and powder

(L)-ASPARTIC ACID Indication

There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.

(L)-ASPARTIC ACID Pharmacology

L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.

(L)-ASPARTIC ACID Absorption

Absorbed from the small intestine by an active transport process

(L)-ASPARTIC ACID side effects and Toxicity

Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.

(L)-ASPARTIC ACID Patient Information

No information avaliable

(L)-ASPARTIC ACID Organisms Affected

Humans and other mammals